SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brad C. Dunlap who wrote (391)2/27/1997 2:41:00 PM
From: I. Luttichuys   of 1762
 
Hello Brad, Looks like the Nuclear Regulatory Commision has come down with a decision which, at least according to CLTR, will allow "almost any patient" undergoing radioimmunotherapy to be treated on an outpatient basis. This was released yesterday and my gut feeling is that this, in combination with the possibility of resistance at the 24/25 level, may be our culprits as far as recent weakness.
How does it look on your end?
Hope you are enjoying your day,
BENNETT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News